KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Q3 2025 value amounting to $31.6 million.

  • Aurinia Pharmaceuticals' Consolidated Net Income rose 12052.84% to $31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.9 million, marking a year-over-year increase of 44339.07%. This contributed to the annual value of $5.7 million for FY2024, which is 10736.27% up from last year.
  • Aurinia Pharmaceuticals' Consolidated Net Income amounted to $31.6 million in Q3 2025, which was up 12052.84% from $21.5 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Consolidated Net Income registered a high of $31.6 million during Q3 2025, and its lowest value of -$50.4 million during Q1 2021.
  • For the 5-year period, Aurinia Pharmaceuticals' Consolidated Net Income averaged around -$15.0 million, with its median value being -$13.4 million (2023).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 9427.35% in 2021, then surged by 307300.88% in 2025.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Consolidated Net Income stood at -$33.3 million in 2021, then increased by 21.84% to -$26.0 million in 2022, then fell by 3.34% to -$26.9 million in 2023, then soared by 105.47% to $1.5 million in 2024, then skyrocketed by 2041.96% to $31.6 million in 2025.
  • Its Consolidated Net Income was $31.6 million in Q3 2025, compared to $21.5 million in Q2 2025 and $23.3 million in Q1 2025.